PROQR THRAPEUTICS N V shareholders Q3 2023

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

PROQR THRAPEUTICS N V shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
Atom Investors LP 13,107$17,0390.00%
BOOTHBAY FUND MANAGEMENT, LLC 95,745$124,4690.00%
PFS Partners, LLC 1,000$1,3000.00%
TWO SIGMA INVESTMENTS, LP 180,744$234,9670.00%
OneDigital Investment Advisors LLC 19,525$25,3830.00%
Cutler Group LLC / CA 4,600$50.00%
MACQUARIE GROUP LTD 620,000$806,0000.00%
TWO SIGMA ADVISERS, LP 228,200$296,6600.00%
Csenge Advisory Group 10,000$13,0000.00%
Vanguard Personalized Indexing Management, LLC 21,429$27,8580.00%
External links

This page lists PROQR THRAPEUTICS N V's shareholders in Q3 2023. To view PROQR THRAPEUTICS N V's shareholder history, click here.